Recent work has shown that in a toxin-based mouse model of parkinsonism the MSN sub-type expressing the D2 dopamine receptor undergoes selective dendritic spine loss, while neighboring MSN expressing the D1 dopamine receptor are largely unaffected [73]. This evidence concerns the gene DRD2 and Parkinsonism.